Skip to content

Dr. Jelena Heirbaut

Active
Private limited companyfounded 2023active for 3 yearsCallaertstraat(S.) 44, 1800 Vilvoorde, BelgiumKBO/BCE: BE 0804.823.747

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Jelena Heirbaut has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €207,551 and a net result of €104,989. Equity has been growing by about 90% per year since 2023. Its solvency ranks better than 80% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 16-08-2023 Normal situation
Legal form
Private limited company
Registered office
Callaertstraat(S.) 44, 1800 Vilvoorde
Activity
Specialist medical practice NACE 86220
Establishment unit
2.348.434.435 1800 Vilvoorde, since 16-08-2023
Financial year end
31 December
Peppol
Reachable since 11-02-2025

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€138,452
▲ 35.2%
Turnover
≈ €260,000
estimated
Profit
€104,989
▲ 32.3%
Equity
€207,551
▲ 102%
Total assets
€237,435
▲ 93.2%
2025 accounts filed 21 days after the deadline
Filed on 21-08-2026at the National Bank
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 7.65, cash €188,788Equity €207,551 (87.4% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 85% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 87.4% of total assets
Liquidity 98+2
short-term debt 12.6% · cash 79.5%
Profitability 100=
return on assets 44.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.2 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 7.65 (5.47 in 2024), above the usual 1.5. Short-term debt is 12.6% and cash 79.5% of total assets. 12.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 88% on liquidity, 80% on profitability and 90% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 7.65, cash €188,788
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Equity €207,551 (87.4% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 21 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-08-2026, 21 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
21 days late
2024
28 days late
2023
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 26 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Equity rose in 2025from €102,563 to €207,551 ▲ 102% View
  • Positive: Higher solvency than 80% of companies in human healthsector median 63.0% · 20,678 companies 87.4% View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Jelena Heirbaut

What is the company number of Dr. Jelena Heirbaut?
The company number of Dr. Jelena Heirbaut is 0804.823.747. The VAT number is the same number with BE in front: BE 0804.823.747.
Where is Dr. Jelena Heirbaut based?
The registered office is at Callaertstraat(S.) 44, 1800 Vilvoorde.Company details
What does Dr. Jelena Heirbaut do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Jelena Heirbaut?
The legal form of Dr. Jelena Heirbaut is Private limited company (BV).
When was Dr. Jelena Heirbaut founded?
Dr. Jelena Heirbaut was founded on 16-08-2023.
Is Dr. Jelena Heirbaut still active?
Yes, Dr. Jelena Heirbaut is an active enterprise in the KBO register.
What is the turnover of Dr. Jelena Heirbaut?
The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €138,452 and 43 comparable companies (NACE 86220). It probably lies between €220,000 and €340,000.Financials
Is Dr. Jelena Heirbaut profitable?
In financial year 2025, Dr. Jelena Heirbaut made a profit of €104,989.
Where can I find the annual accounts of Dr. Jelena Heirbaut?
Dr. Jelena Heirbaut filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Jelena Heirbaut due?
Dr. Jelena Heirbaut must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as Dr. Jelena Heirbaut: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €207,000 and €271,000, founded in 2023.

CompanyTotal assetsGross margin
Dr. Jelena Heirbaut Vilvoorde€237,435€138,452
Dr. Vincent Kabir, Neuroloog Herent€242,436€141,651
Koen Norga Kinderarts Aarschot€271,262€143,684
Dr. EVH, oogarts Leuven€210,575€130,742
SIANDRO Herent€242,063€155,831
Leticia Barrios Cardiologie Bierbeek€207,335€128,408
Dr. J. Decoene Bertem€256,423€157,480
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.